• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对半乳糖缺乏 IgA1 的自身抗体与 IgA 肾病的进展相关。

Autoantibodies targeting galactose-deficient IgA1 associate with progression of IgA nephropathy.

机构信息

Nephrology, Dialysis, and Renal Transplantation Department, University North Hospital, 42055 Saint-Etienne Cedex 2, France.

出版信息

J Am Soc Nephrol. 2012 Sep;23(9):1579-87. doi: 10.1681/ASN.2012010053. Epub 2012 Aug 16.

DOI:10.1681/ASN.2012010053
PMID:22904352
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3431415/
Abstract

Mesangial and circulating IgA1 with aberrantly glycosylated hinge region O-glycans characterize IgA nephropathy (IgAN). Unlike healthy individuals, some IgA1 is galactose deficient in patients with IgAN, leaving terminal N-acetylgalactosamine residues in the hinge region exposed. Circulating autoantibodies that recognize such galactose-deficient IgA1 as an autoantigen, or the levels of the autoantigen itself, may allow prediction of disease progression. Here, we analyzed serum samples obtained at diagnosis for autoantigen and autoantibodies from 97 patients with IgAN selected from our prospective cohort according to their absolute renal risk for progression to dialysis or death (0, very low; 1, low; 2, high; 3, very high). We also analyzed samples from controls comprising 30 healthy volunteers and 30 patients with non-IgAN disease. The mean follow-up was 13.8 years. We found that mean serum levels of total autoantigen, normalized IgG autoantibody, and total IgA autoantibody were significantly higher in patients than in the combined controls (all P≤0.01). Furthermore, increasing levels correlated with worse clinical outcomes. In Cox regression and Kaplan-Meier analyses, IgG autoantibody levels ≥1.33 predicted dialysis or death (both P≤0.01). In conclusion, these data suggest that serum levels of IgG and IgA autoantibodies strongly associate with the progression of IgAN nephropathy.

摘要

系膜和循环 IgA1 具有异常糖基化铰链区 O-聚糖,是 IgA 肾病(IgAN)的特征。与健康个体不同,一些 IgA1 在 IgAN 患者中缺乏半乳糖,使铰链区暴露末端 N-乙酰半乳糖胺残基。识别这种缺乏半乳糖的 IgA1 作为自身抗原的循环自身抗体,或自身抗原本身的水平,可能允许预测疾病进展。在这里,我们根据绝对肾脏进展为透析或死亡的风险(0,极低;1,低;2,高;3,极高),从我们的前瞻性队列中选择了 97 例 IgAN 患者的诊断时血清样本,分析了来自自身抗原和自身抗体的分析物。我们还分析了来自包括 30 名健康志愿者和 30 名非 IgAN 疾病患者的对照样本。平均随访时间为 13.8 年。我们发现,与合并对照组相比,患者的总自身抗原、归一化 IgG 自身抗体和总 IgA 自身抗体的血清水平明显更高(均 P≤0.01)。此外,水平升高与更差的临床结局相关。在 Cox 回归和 Kaplan-Meier 分析中,IgG 自身抗体水平≥1.33 预测透析或死亡(均 P≤0.01)。总之,这些数据表明,IgG 和 IgA 自身抗体的血清水平与 IgAN 肾病的进展密切相关。

相似文献

1
Autoantibodies targeting galactose-deficient IgA1 associate with progression of IgA nephropathy.针对半乳糖缺乏 IgA1 的自身抗体与 IgA 肾病的进展相关。
J Am Soc Nephrol. 2012 Sep;23(9):1579-87. doi: 10.1681/ASN.2012010053. Epub 2012 Aug 16.
2
Recurrent IgA nephropathy is predicted by altered glycosylated IgA, autoantibodies and soluble CD89 complexes.反复性 IgA 肾病可由糖基化 IgA、自身抗体和可溶性 CD89 复合物改变所预测。
Kidney Int. 2015 Oct;88(4):815-22. doi: 10.1038/ki.2015.158. Epub 2015 Jun 10.
3
Galactose-deficient IgA1 and the corresponding IgG autoantibodies predict IgA nephropathy progression.半乳糖缺乏 IgA1 及其相应的 IgG 自身抗体可预测 IgA 肾病进展。
PLoS One. 2019 Feb 22;14(2):e0212254. doi: 10.1371/journal.pone.0212254. eCollection 2019.
4
Serum galactose-deficient-IgA1 and IgG autoantibodies correlate in patients with IgA nephropathy.在IgA肾病患者中,血清半乳糖缺乏IgA1和IgG自身抗体存在相关性。
PLoS One. 2018 Jan 11;13(1):e0190967. doi: 10.1371/journal.pone.0190967. eCollection 2018.
5
The level of galactose-deficient IgA1 in the sera of patients with IgA nephropathy is associated with disease progression.IgA 肾病患者血清中半乳糖缺乏 IgA1 的水平与疾病进展有关。
Kidney Int. 2012 Oct;82(7):790-6. doi: 10.1038/ki.2012.197. Epub 2012 Jun 6.
6
Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1 and soluble CD89-IgA and IgG-IgA complexes: common mechanisms for distinct diseases.IgA 肾病和酒精性肝硬化的特征均为异常糖基化 IgA1 和可溶性 CD89-IgA 以及 IgG-IgA 复合物:不同疾病的共同发病机制。
Kidney Int. 2011 Dec;80(12):1352-63. doi: 10.1038/ki.2011.276. Epub 2011 Aug 24.
7
Oxidative stress and galactose-deficient IgA1 as markers of progression in IgA nephropathy.氧化应激和半乳糖缺乏 IgA1 作为 IgA 肾病进展的标志物。
Clin J Am Soc Nephrol. 2011 Aug;6(8):1903-11. doi: 10.2215/CJN.11571210. Epub 2011 Jul 22.
8
Clinical significance of serum and mesangial galactose-deficient IgA1 in patients with IgA nephropathy.血清和系膜区半乳糖缺失 IgA1 在 IgA 肾病患者中的临床意义。
PLoS One. 2018 Nov 2;13(11):e0206865. doi: 10.1371/journal.pone.0206865. eCollection 2018.
9
Characteristics of patients with coexisting IgA nephropathy and membranous nephropathy.同时患有 IgA 肾病和膜性肾病患者的特征。
Ren Fail. 2018 Nov;40(1):213-218. doi: 10.1080/0886022X.2018.1455591.
10
Glomerular Immunodeposits of Patients with IgA Nephropathy Are Enriched for IgG Autoantibodies Specific for Galactose-Deficient IgA1.IgA 肾病患者肾小球免疫沉积物富含针对半乳糖缺乏 IgA1 的 IgG 自身抗体。
J Am Soc Nephrol. 2019 Oct;30(10):2017-2026. doi: 10.1681/ASN.2018111156. Epub 2019 Aug 23.

引用本文的文献

1
Intraglomerular Inflammation as a Guide for Mycophenolate Mofetil-Based Treatment in IgA Nephropathy.肾小球内炎症作为IgA肾病中以霉酚酸酯为基础治疗的指导
Diagnostics (Basel). 2025 Aug 20;15(16):2101. doi: 10.3390/diagnostics15162101.
2
Glycosylation in kidney diseases.肾脏疾病中的糖基化作用。
Precis Clin Med. 2025 Jul 11;8(3):pbaf017. doi: 10.1093/pcmedi/pbaf017. eCollection 2025 Sep.
3
Serum IgE and IgA Levels in Pediatric Henoch-Schönlein Purpura: Clinical Characteristics and Immunological Correlations in the Context of Infectious Diseases-A Five-Year Retrospective Analysis.儿童过敏性紫癜血清IgE和IgA水平:传染病背景下的临床特征及免疫相关性——一项五年回顾性分析
Int J Mol Sci. 2025 Jun 24;26(13):6053. doi: 10.3390/ijms26136053.
4
Gut microbiota as a predictive tool for outcomes in IgA nephropathy.肠道微生物群作为IgA肾病预后的预测工具
Ren Fail. 2025 Dec;47(1):2514184. doi: 10.1080/0886022X.2025.2514184. Epub 2025 Jul 9.
5
cnm-positive Streptococcus mutans, a major pathogen in dental caries, may exacerbate IgA nephropathy via the tonsils.致龋主要病原菌变形链球菌的致龋菌表面蛋白(Cnm)阳性菌株可能通过扁桃体加重IgA肾病。
Clin Exp Nephrol. 2025 May 29. doi: 10.1007/s10157-025-02708-6.
6
Prognostic Value of Urinary Biomarkers in Proteinuria Progression in IgA Nephropathy Patients Treated with Budesonide.布地奈德治疗的IgA肾病患者蛋白尿进展中尿生物标志物的预后价值
Medicina (Kaunas). 2025 Apr 26;61(5):807. doi: 10.3390/medicina61050807.
7
Modern Biomarkers in IgA Nephropathy and Their Potential in Paediatric Research.IgA肾病中的现代生物标志物及其在儿科研究中的潜力
J Clin Med. 2025 May 7;14(9):3263. doi: 10.3390/jcm14093263.
8
Immune cells mediate the effect of plasma lipidomes on IgA nephropathy: a Mendelian randomization study.免疫细胞介导血浆脂质组对IgA肾病的影响:一项孟德尔随机化研究
Ren Fail. 2025 Dec;47(1):2498631. doi: 10.1080/0886022X.2025.2498631. Epub 2025 May 6.
9
Emerging Biochemical and Immunologic Mechanisms in the Pathogenesis of IgA Nephropathy.IgA肾病发病机制中的新兴生化和免疫机制
Semin Nephrol. 2024 Sep;44(5):151565. doi: 10.1016/j.semnephrol.2025.151565. Epub 2025 Mar 13.
10
Exploring the causal role of pathogen-derived antibodies in major urinary and kidney diseases: Insights from generalized summary data-based Mendelian randomization.探索病原体衍生抗体在主要泌尿系统和肾脏疾病中的因果作用:基于广义汇总数据的孟德尔随机化研究的见解
Virulence. 2025 Dec;16(1):2473631. doi: 10.1080/21505594.2025.2473631. Epub 2025 Mar 11.

本文引用的文献

1
An update on the pathogenesis and treatment of IgA nephropathy.IgA 肾病发病机制与治疗的研究进展。
Kidney Int. 2012 May;81(9):833-43. doi: 10.1038/ki.2011.501. Epub 2012 Feb 8.
2
Novel metrics for evaluating improvement in discrimination: net reclassification and integrated discrimination improvement for normal variables and nested models.用于评估判别改善的新指标:适用于正态变量和嵌套模型的净重新分类和综合判别改善。
Stat Med. 2012 Jan 30;31(2):101-13. doi: 10.1002/sim.4348. Epub 2011 Dec 7.
3
The pathophysiology of IgA nephropathy.IgA 肾病的病理生理学。
J Am Soc Nephrol. 2011 Oct;22(10):1795-803. doi: 10.1681/ASN.2011050464. Epub 2011 Sep 23.
4
IgA1 immune complexes from pediatric patients with IgA nephropathy activate cultured human mesangial cells.IgA1 免疫复合物来自患有 IgA 肾病的儿科患者,可激活培养的人肾小球系膜细胞。
Nephrol Dial Transplant. 2011 Nov;26(11):3451-7. doi: 10.1093/ndt/gfr448. Epub 2011 Aug 9.
5
Oxidative stress and galactose-deficient IgA1 as markers of progression in IgA nephropathy.氧化应激和半乳糖缺乏 IgA1 作为 IgA 肾病进展的标志物。
Clin J Am Soc Nephrol. 2011 Aug;6(8):1903-11. doi: 10.2215/CJN.11571210. Epub 2011 Jul 22.
6
Equivalence of improvement in area under ROC curve and linear discriminant analysis coefficient under assumption of normality.在正态假设下,ROC 曲线下面积的改善与线性判别分析系数的等价性。
Stat Med. 2011 May 30;30(12):1410-8. doi: 10.1002/sim.4196. Epub 2011 Feb 21.
7
Aberrant glycosylation of IgA1 is inherited in both pediatric IgA nephropathy and Henoch-Schönlein purpura nephritis.IgA1 的异常糖基化在儿童 IgA 肾病和过敏性紫癜性肾炎中均为遗传性的。
Kidney Int. 2011 Jul;80(1):79-87. doi: 10.1038/ki.2011.16. Epub 2011 Feb 16.
8
Immunostaining findings in IgA nephropathy: correlation with histology and clinical outcome in the Oxford classification patient cohort.IgA 肾病的免疫染色结果:与牛津分类患者队列的组织学和临床结局的相关性。
Nephrol Dial Transplant. 2011 Aug;26(8):2533-6. doi: 10.1093/ndt/gfq812. Epub 2011 Jan 27.
9
Predicting the risk for dialysis or death in IgA nephropathy.预测 IgA 肾病患者发生透析或死亡的风险。
J Am Soc Nephrol. 2011 Apr;22(4):752-61. doi: 10.1681/ASN.2010040355. Epub 2011 Jan 21.
10
Galactose-deficient IgA1 in African Americans with IgA nephropathy: serum levels and heritability.非裔美国人 IgA 肾病患者中缺乏半乳糖的 IgA1:血清水平和遗传性。
Clin J Am Soc Nephrol. 2010 Nov;5(11):2069-74. doi: 10.2215/CJN.03270410. Epub 2010 Jul 15.